Metastatic pattern at autopsy in non-resectable adenocarcinoma of the lung - A study from a cohort of 259 consecutive patients treated with chemotherapy

Acta Oncologica

Volumn 36, Issue 3, 1997, Pages 301-306

  Stenbygaard, Lars E ^a   Sørensen, Jens B ^b   Olsen, Jens E ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; METHOTREXATE;

ADULT; AGED; ARTICLE; AUTOPSY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

EID: 0030998840     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709001267     Document Type: Article

References (27)

1. Sørensen JB, Badsberg JH, Olsen JE. Prognostic factors in inoperable adenocarcinoma of the lung: A multivariate regression analysis of 259 patients. Cancer Res 1989; 49: 5748-54.
2. Hansen HH. Advanced non-small cell lung cancer. To treat or not treat? J Clin Oncol 1987; 5: 1711-12.
3. Sørensen JB, Badsherg JH, Hansen HH. Response to cytostatic treatment in inoperable adenocarcinoma of the lung. Clinical implications. Br J Cancer 1989; 60: 389-93.
4. Elliot JA, Østerlind K, Hirsch FR, Hansen HH. Metastatic pattern in small-cell lung cancer: Correlation of autopsy findings with clinical parameters in 537 patients. J Clin Oncol 1987; 5: 246-54.
5. Storm HH, Andersen J. Percentage of autopsies in cancer patients in Denmark in 1971-1980. Ugeskr Læger 1986; 148: 1110-4. (in Danish).
6. Roberts WC. The autopsy: Its decline and a suggestion for its revival. N Engl J Med 1978; 299: 332-8.
7. Geller SA. Autopsy. Sci Am 1983; 2: 124-36.
8. Greenberg ER, Korson R, Baker J, Barrett J, Baron JA, Yates J. Incidence of lung cancer by cell type: A population-based study in New Hampshire and Vermont. JNCI 1984; 72: 599-603.
9. Budinger JM. Untreated bronchogenic carcinoma. Cancer 1958; 11: 106-16.
10. Abrams HL, Spiro R, Goklstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 1950; 13: 74-85.
11. Engelman RM, McNamara WL. Bronchogenic carcinoma. A statistical review of 234 autopsies. J Thorac Surg 1954; 27: 227-37.
12. Gulluzzi S, Payne PM. Bronchial carcinoma: A statistical study of 741 necropsies with special reference to the distribution of blood-bone metastases. Br J Cancer 1955; 9: 511-27.
13. Guillan RA, Zelman S, Alonso RA. Adenocarcinoma of the lungs. An analysis of 24 cases in men. Am J Clin Pathol 1967; 47: 580-4.
14. Onuigbo WIB. Some pathological data on 2000 adenocarcinemas and squamos cell carcinomas of the lung. Br J Cancer 1963; 17: 1-7.
15. Notter M, Schwegler N. Metastaseninzidenz und verteilungsmunster beim bronchuskarzinom (German). Deutsche Medizinsche Wochenscrift L 1989; 114: 343-9.
16. Oehler W, Lichhorn HJ. Autopsy and clinical findings in case of metastases of the bronchial carcinoma. Study about 649 intensively irradiated patients (in German). Strahlentherapie 1983; 159: 669-75.
17. Sørensen JB, Hansen HH, Dombernowsky P, et al. Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs. J Clin Oncol 1987; 5: 1169-77.
18. World Health Organisation. Histological typing of lung tumors, 2. edition. Geneva: WHO, 1981; 1-41.
19. Mountain CF. The new international system for staging of lung cancer. Chest. 1986; 89 (Suppl): 225S-33S.
20. WHO: Handbook for reporting results of cancer treatment. Geneva: World Health Organizaton, 1979.
21. Koletsky S. Primary carcinoma of the lung. A clinical and pathologic study of one hundred cases. Arch Int Med 1938; 62: 636-51.
22. Strauss B, Weller CV. Broncogenic carcinoma. Arch Pathol 1957; 63: 602-11.
23. Sørensen JB. Prognosis and prognostic factors in adenocarcinoma of the lung. (Thesis). Dan Med Bull 1992; 39: 453-63.
24. Yesner R, Carter D. Pathology of carcinoma of the lung. Changing patterns. Clin in Chest Med 1982; 2: 257-89.
25. Cox JD, Yesner R. Adenocarcinoma of the lung. Recent results from the Veterans Administration Lung Group. Am Rev Resp Dis 1979; 120: 1025-29.
26. Sørensen JB, Hansen HH, Dombernowsky P. Brain metastases in adenocarcinoma of the lung. Frequency, risk groups and prognosis. J Clin Oncol 1988; 6: 1474-80.
27. Slebos RJC, Kibbelaar RE, Dalesio O, et al. K-RAS oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323: 561-5.